These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
733 related items for PubMed ID: 28084708
1. Respiratory Syncytial Virus Bronchiolitis in Children. Smith DK, Seales S, Budzik C. Am Fam Physician; 2017 Jan 15; 95(2):94-99. PubMed ID: 28084708 [Abstract] [Full Text] [Related]
5. Respiratory syncytial virus infection in children. Dawson-Caswell M, Muncie HL. Am Fam Physician; 2011 Jan 15; 83(2):141-6. PubMed ID: 21243988 [Abstract] [Full Text] [Related]
6. Respiratory Syncytial Virus is the Most Common Causative Agent of Viral Bronchiolitis in Young Children: An Updated Review. Hon KL, Leung AKC, Wong AHC, Dudi A, Leung KKY. Curr Pediatr Rev; 2023 Jan 15; 19(2):139-149. PubMed ID: 35950255 [Abstract] [Full Text] [Related]
7. Admission to the intensive care unit for respiratory syncytial virus bronchiolitis: a national survey before palivizumab use. Prais D, Schonfeld T, Amir J, Israeli Respiratory Syncytial Virus Monitoring Group. Pediatrics; 2003 Sep 15; 112(3 Pt 1):548-52. PubMed ID: 12949282 [Abstract] [Full Text] [Related]
8. Management and prevention strategies for respiratory syncytial virus (RSV) bronchiolitis in infants and young children: a review of evidence-based practice interventions. Cooper AC, Banasiak NC, Allen PJ. Pediatr Nurs; 2003 Sep 15; 29(6):452-6. PubMed ID: 14743842 [Abstract] [Full Text] [Related]
15. Updated guidance for palivizumab prophylaxis among infants and young children at increased risk of hospitalization for respiratory syncytial virus infection. American Academy of Pediatrics Committee on Infectious Diseases, American Academy of Pediatrics Bronchiolitis Guidelines Committee. Pediatrics; 2014 Aug 15; 134(2):e620-38. PubMed ID: 25070304 [Abstract] [Full Text] [Related]
16. Revised indications for the use of palivizumab and respiratory syncytial virus immune globulin intravenous for the prevention of respiratory syncytial virus infections. American Academy of Pediatrics Committee on Infectious Diseases and Committee on Fetus and Newborn. Pediatrics; 2003 Dec 15; 112(6 Pt 1):1442-6. PubMed ID: 14654627 [Abstract] [Full Text] [Related]
18. Observed Effectiveness of Palivizumab for 29-36-Week Gestation Infants. Farber HJ, Buckwold FJ, Lachman B, Simpson JS, Buck E, Arun M, Valadez AM, Ruiz T, Alonzo J, Henry A, Cos-Okpalla N, Nguyen K, Brendel W, Small J, Glomb WB. Pediatrics; 2016 Aug 15; 138(2):. PubMed ID: 27432850 [Abstract] [Full Text] [Related]
19. Bronchiolitis: the new American Academy of Pediatrics guidelines. Corsello G. J Chemother; 2007 Oct 15; 19 Suppl 2():12-4. PubMed ID: 18073171 [Abstract] [Full Text] [Related]